ALFA Finder
19:56 IST
BSE
Other Announcement
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Ltd
- Share price
- ₹489.95
- Market cap
- ₹4,472 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 19.5×Sector 43.8×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 3Earnings Call 2Board Meeting Date 2Annual General Meeting 2Results Update 1Management Change 1Financial Results 1Employee Stock Options 1Business Update 1Annual Report 1
Time
3 announcements with these filters
19:08 IST
BSE
Other Announcement
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
19:20 IST
BSE
Other Announcement
Aarti Drugs Other Announcement
Aarti Drugs Ltd has submitted its quarterly shareholding pattern in compliance with Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended June 30, 2026.